Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
- Herman J Ng, E. R. Whittemore, +6 authors K. Gee
- Chemistry, MedicineProceedings of the National Academy of Sciences
- 8 May 2007
A selective α7 nAChR-positive allosteric modulator (PAM) from a library of GABAA receptor PAMs is generated, which corrects sensory-gating deficits and improves working memory, effects consistent with cognitive enhancement in rodent models.
1,1-Dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP): A Solvent Polarity and Viscosity Sensitive Fluorophore for Fluorescence Microscopy⊥
1,1-Dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (II, DDNP) has been synthesized as a fluorescent dye whose intramolecular rotational relaxation is solvent polarity and viscosity dependent.…
Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in Rats
- R. Yoshimura, D. Hogenkamp, +5 authors K. Gee
- Psychology, MedicineJournal of Pharmacology and Experimental…
- 1 December 2007
UCI-30002 represents validation of the concept that negative allosteric modulators may have significant benefits as a strategy for treating nicotine addiction and encourages the development of subtype-selective modulators.
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
The trial demonstrates that a type I PAM can be safely administered to humans and that it has potential positive neurocognitive effects in central nervous system (CNS) disorders.
Allosteric Modulation of Related Ligand-Gated Ion Channels Synergistically Induces Long-Term Potentiation in the Hippocampus and Enhances Cognition
- Timothy B C Johnstone, Z. Gu, +8 authors K. Gee
- Chemistry, MedicineJournal of Pharmacology and Experimental…
- 1 March 2011
Combined transient application of two allosteric modulators that individually inhibit α5 GABAARs and enhance α7 nAChRs causes long-term potentiation of mossy fiber stimulation-induced excitatory postsynaptic currents (EPSC) from CA1 pyramidal neurons of rat hippocampal slices.
Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model
It is suggested that compounds that have selective activities at GABAAR subtypes and the &agr;7 nAChR PAMs may address the core symptoms and comorbidities of autism.
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid
- D. Hogenkamp, M. Tran, R. Yoshimura, Timothy B C Johnstone, R. Kanner, K. Gee
- 28 February 2014
UCI-50027 is an orally active neuroactive steroid with pharmacological activity consistent with a gamma-aminobutyric acid(A) receptor PAM that has an improved separation between anticonvulsant/anxiolytic and rotarod effects, potent activity as an anticonVulsant and anxIOlytic when compared to ganaxolone.
Modifying quinolone antibiotics yields new anxiolytics
Patients taking fluoroquinolone antibiotics such as norfloxacin exhibit a low incidence of convulsions and anxiety. These side effects probably result from antagonism of the neurotransmitter…
Limiting Activity at β1-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia
- K. Gee, M. Tran, +6 authors E. R. Whittemore
- Biology, MedicineJournal of Pharmacology and Experimental…
- 1 March 2010
These findings provide an alternative strategy for designing anxioselective allosteric modulators of the GABAAR with BZ-like anxiolytic efficacy by reducing or eliminating activity at β1-subunit-containing GABAARs.
Reversible lipidization for the oral delivery of leu-enkephalin
- Jeffrey R. Wang, D. Hogenkamp, +5 authors K. Gee
- Chemistry, MedicineJournal of drug targeting
- 1 January 2006
The results indicate that like its disulfide-based counterpart, amine-based REAL may be an enabling technology which can be applied to enhance metabolic stability, increase oral absorption, and preserve and possibly prolong the pharmacological activity of peptide drugs.